Correlation Between CytomX Therapeutics and Bio Path
Can any of the company-specific risk be diversified away by investing in both CytomX Therapeutics and Bio Path at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CytomX Therapeutics and Bio Path into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CytomX Therapeutics and Bio Path Holdings, you can compare the effects of market volatilities on CytomX Therapeutics and Bio Path and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CytomX Therapeutics with a short position of Bio Path. Check out your portfolio center. Please also check ongoing floating volatility patterns of CytomX Therapeutics and Bio Path.
Diversification Opportunities for CytomX Therapeutics and Bio Path
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between CytomX and Bio is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and Bio Path Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Path Holdings and CytomX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CytomX Therapeutics are associated (or correlated) with Bio Path. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Path Holdings has no effect on the direction of CytomX Therapeutics i.e., CytomX Therapeutics and Bio Path go up and down completely randomly.
Pair Corralation between CytomX Therapeutics and Bio Path
Given the investment horizon of 90 days CytomX Therapeutics is expected to generate 0.86 times more return on investment than Bio Path. However, CytomX Therapeutics is 1.16 times less risky than Bio Path. It trades about 0.03 of its potential returns per unit of risk. Bio Path Holdings is currently generating about -0.24 per unit of risk. If you would invest 101.00 in CytomX Therapeutics on August 29, 2024 and sell it today you would earn a total of 1.00 from holding CytomX Therapeutics or generate 0.99% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
CytomX Therapeutics vs. Bio Path Holdings
Performance |
| Timeline |
| CytomX Therapeutics |
| Bio Path Holdings |
CytomX Therapeutics and Bio Path Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CytomX Therapeutics and Bio Path
The main advantage of trading using opposite CytomX Therapeutics and Bio Path positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CytomX Therapeutics position performs unexpectedly, Bio Path can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Path will offset losses from the drop in Bio Path's long position.| CytomX Therapeutics vs. Spero Therapeutics | CytomX Therapeutics vs. Instil Bio | CytomX Therapeutics vs. NextCure | CytomX Therapeutics vs. Assembly Biosciences |
| Bio Path vs. Capricor Therapeutics | Bio Path vs. NextCure | Bio Path vs. Pulmatrix | Bio Path vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |